newratings.com  Mar 30  Comment 
WASHINGTON (dpa-AFX) - Actinium Pharmaceuticals, Inc. (ATNM) announced that the U.S. Food and Drug Administration has granted orphan drug designation for Iomab-B, a radioimmunotherapeutic that conditions relapsed and refractory Acute Myeloid...
newratings.com  Nov 23  Comment 
WASHINGTON (dpa-AFX) - Actinium Pharmaceuticals Inc. (ATNM) announced that it has filed an Application for Orphan Drug Designation with the U.S. Food and Drug Administration for Iomab-B, a radioimmunotherapeutic that conditions refractory and...
Benzinga  Jun 5  Comment 
In a report published Friday, Roth Capital analyst Joseph Pantginis reiterated a Buy rating and $4 price target on Palatin Technologies, Inc. (NYSE: PTN). The majority positive vote for flibanserin by the FDA Advisory Committee bodes well for...
WA Business News  Jul 30  Comment 
Perth-based marine and coastal environmental specialist BMT Oceanica has been selected to provide ocean outlet monitoring services for the Water Corporation.
WA Business News  Jul 14  Comment 
Perth-based marine environment specialist BMT Oceanica has formed a partnership with aquaculture advisory group SmartAqua, ahead of major growth predicted in the industry.
WA Business News  May 30  Comment 
Perth-based marine environment specialist BMT Oceanica has been appointed lead consultant in a state government bid to establish an aquaculture development zone in the southern Abrolhos islands.
StreetInsider.com  Feb 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ThermoGenesis+%28KOOL%29%2C+TotipotentRX+Reach+20th+Pediatric+BMT+Milestone/9116174.html for the full story.
OilVoice  Oct 25  Comment 
BMT Scientific Marine Services Inc BMT has been awarded a contract from SBM Offshore to provide an Integrated Marine Monitoring System IMMS for the Stones Floating Production Storage Offshore FPS
Benzinga  Oct 1  Comment 
Pluristem Therapeutics (NASDAQ: PSTI) announced today that the company's PLacental eXpanded (PLX) cells demonstrated efficacy in a preliminary animal experiment for the treatment of Graft versus Host Disease (GvHD) following bone marrow...
Benzinga  May 7  Comment 
Pluristem Therapeutics Inc. (NASDAQ: PSTI) announced today that it has identified its first clinical indication in the hematology field for its Placental eXpanded (PLX) RAD cells for the enhancement of the engraftment of Hematopoietic Stem Cells...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki